Patient centricity in clinical development: the secret to success in pharma industry
Implementing patient centricity in clinical development can prove to be beneficial in many ways. This approach helps pharmaceutical companies improve the efficiency of their clinical trials and research outcomes. This ensures that the drug or treatment plan completely aligns with the real-world needs of patients and their daily lifestyle habits.
Clinical development is one of the key pillars of the healthcare sector. This is the systematic process of testing new drugs, vaccines, and other treatment methods and making them available in the market. Until recently, this entire process used to be primarily science-centered. The complete focus remained on statistical mechanisms and biological endpoints. But as things changed and patient-centricity became the industry's latest buzzword, the clinical development process also evolved. Nowadays, it is being designed by keeping patient convenience in mind.
What is patient centricity?
Nowadays, patients are not just the recipients of a treatment plan but active partners in the overall process. This is why the healthcare industry is making a quick shift towards patient centricity.
As the name suggests, it is the concept of placing patients at the heart of every single decision. From performing the initial research for developing a drug, performing multi-level clinical trials, building marketing strategies to offering post-launch support for a product/service, everything is done while prioritizing the needs and preferences of patients.
Following this approach allows pharma companies to achieve better health outcomes and ensure higher patient satisfaction.
Role in clinical development
Clinical development often involves strict timelines, complex procedures and various regulatory hurdles. Every clinical trial needs human participants so that researchers can understand whether the new drug, vaccine, or treatment plan is safe and effective or not. When patient insights are integrated into study design and execution, the overall recruitment and retention rate of a clinical trial can be increased. This eventually results in more relevant and effective research outcomes.
Benefits of patient centricity in clinical development
Adopting a patient-centric approach in clinical development solutions benefits pharma companies in various ways, like:
-
Improved recruitment and retention: When a clinical trial is designed around patient needs and expectations, it is a lot easier to participate in. This results in a higher enrollment rate and also minimizes the number of dropouts. To further enhance the recruitment and retention rate, many pharma companies also leverage customer experience solution.
-
Better data quality: Every clinical trial generates large amounts of data, which gives a holistic view of the particular treatment’s effects. Patient-centric trials often lead to data that are more reflective of real-world scenarios. This makes the data more accurate and very useful in understanding the true impact of the drug.
-
More relevant outcomes: The main problem with the traditional science-centered clinical development process is that endpoints cannot always capture the real-world impact. But the new patient-centric approach ensures that the feedback from participants is incorporated, improving overall outcomes.
-
Operational efficiency: Integrating patient-reported outcomes into clinical development solutions also allows pharma companies to streamline their operations. This results in enhanced efficiency.
Final Thought
The future of clinical development is increasingly becoming patient-centric. The entire focus is no longer on regulatory and scientific requirements only. Every single stage of this process also integrates the needs, preferences and experiences of patients. This helps in achieving safer and more effective drugs and treatment plans. Pharmaceutical companies that are embracing this new approach are moving steadily on the path of success.


